Daniel V. Santi, M.D., Ph.D Co-Founder & President
Gary W. Ashley, Ph.D Co-Founder & CSO
Company Description
ProLynx is a privately held biotechnology company developing proprietary drug delivery systems for half-life extension of proteins, peptides and small molecules.